Nuformix (LSE:NFX) Change In Payables And Accrued Expense : £0.00 Mil (TTM As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Nuformix Change In Payables And Accrued Expense?

Nuformix's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was £0.00 Mil. It means Nuformix's Accounts Payable & Accrued Expense stayed the same from Sep. 2024 to Mar. 2025 .

Nuformix's Change In Payables And Accrued Expense for the fiscal year that ended in Sep. 2024 was £0.00 Mil. It means Nuformix's Accounts Payable & Accrued Expense stayed the same from Mar. 2023 to Sep. 2024 .

Nuformix Change In Payables And Accrued Expense Historical Data

The historical data trend for Nuformix's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix Change In Payables And Accrued Expense Chart

Nuformix Annual Data

Trend

Dec15

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Sep24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Nuformix Semi-Annual Data
	Dec15	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Mar24	Sep24	Mar25
Change In Payables And Accrued Expense	Get a 7-Day Free Trial													-	-	-	-	-

Nuformix Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

Nuformix Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Nuformix's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuformix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.nuformix.com

Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.